Michael Nuoqing Yi

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account.

Enspectra Health, Inc. engages in the provision of visualization of cellular structures. It develops micro-endoscopy system. The company was founded by Gabriel Sanchez, Mark Schnitzer, and Scott Delp and is headquartered in Mountain View, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

The Brookings Institution provides research and policy solutions. The firm's activities are carried out through four research programs: economic studies, foreign policy studies, governance studies, and metropolitan policy. The company was founded in 1916 and is headquartered in Washington, DC.

CDP Group Ltd. is a holding company that provides human resource outsourcing services. It offers products such as payroll and benefit outsourcing, SaaS human resource-demand, shared services, recruitment, expatriate, and other value added services. The company was founded by Wayne Wang and Wei Lu on October 21, 2004, and is headquartered in Shanghai, China.

Guangzhou Blue Moon Industry Co., Ltd. engages in the manufacturing of detergent products. The firm offers silk liquid softeners, toilet water cleaners, stain-bleaching liquids, greasy-dirt removing, and ceramic-cleaning detergent products. The company was founded on January 9, 2001 and is headquartered in Guangzhou, China.

BMI Asia, Inc. provides business management initiatives services. The private company is based in Shanghai, China. The Chinese company was founded by Ye Sha.

Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA.

Shanghai Yunfeng Investment Management Co. Ltd (Yunfeng Capital) is a private equity firm founded in 2010 by Feng Yu and Yun Ma. The firm is headquartered in Shanghai, China.

Inscopix, Inc. develops and produces miniature integrated microscopes and related devices. It is categorized under the research and development in the physical, engineering, and life sciences industry. The firm specializes in neuroscience, life science research tools, in vivo brain imaging, electrophysiology, neurotechnology, miniature microscope, calcium imaging areas. The company was founded by Mark Schnitzer, Kunal Ghosh and Abbas El Gamal in 2011 and is headquartered in Palo Alto, CA.

Hillhouse Investment Management Ltd. (HIM) is the wholly owned alternative investment management subsidiary of Hillhouse Group Ltd., ultimately held by Hillhouse Capital Group Ltd., a multinational group headquartered in Hong Kong. The firm was founded by Lei Zhang in 2005 as Hillhouse Capital Management, Ltd. and changed its name to Hillhouse Investment Management, Ltd. in 2021. HIM provides investment advice to global institutional investors as well as to non-profit foundations.

Part of Alibaba Group Holding Ltd., Alibaba.com China Ltd. provides software, technology, online business-to-business and e-commerce services.

China-United States Exchange Foundation is an independent, non-profit and non-governmental foundation that encourages constructive dialogue and diverse exchanges between the people of China and the United States. The foundation is based in Sheung Wan, Hong Kong. Through a series of programs, the foundation provides insights into the US-China relationship at the highest level. The foundation was founded by Chee Hwa Tung in 2011 and has become a go-to source for high-level insight into developments in the US-China relationship, with a special focus on areas of interest.

Hillhouse Capital Group Ltd. operates as an investment management firm. It serves the consumer, TMT, industrials, and healthcare sectors and invests in companies across all equity stages. The company was founded by Zhang Lei in 2005 and is headquartered in Hong Kong.

Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston.

Financial Services Development Council operates as a financial centre. The firm provides information of the FSDC’s activities in relation to the Hong Kong financial services industry, but also the FSDC’s publications on a wide spectrum of topics related to the industry such as the reports on mandatory provident fund system, life insurance as well as Environmental, Social and Governance (ESG).The company is headquartered in Hong Kong.

Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA.

FCLT Global engages as a non-profit organization that develops research and tools that encourage long-term investing. The company was founded by Mark D. Wiseman in 2013 and is headquartered in Boston, MA.

Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA.

Eikonizo Therapeutics, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Beverly, MA.

HHLR Advisors Ltd. (HHLR) is an investment management firm headquartered in Hong Kong. The firm was founded in 2012 as Hillhouse Capital Advisors Ltd. and became HHLR Advisors Ltd. in 2021. They are a wholly-owned subsidiary of Hillhouse Group Ltd., which itself is a wholly owned subsidiary of Hillhouse Group Holdings Ltd. HHLR provides investment advice to clients organized as privately-offered pooled investment vehicles or similar structures and to certain managed accounts or similar relationships.

Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor.

Part of Cutia Therapeutics, Cutia Therapeutics (Shanghai) Co., Ltd. develops therapeutics to treat severe facial acne vulgaris. The company is based in Shanghai, China. The Chinese company was founded in 2019. The CEO is Le Le Zhang.

MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong.

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.